By Robb M. Stewart
Cosciens Biopharma appointed Anna Biehn as the specialty biopharmaceutical company's next chief executive, turning to an executive with more than 25 years experience in the consumer products and biosciences industries.
Biehn will take up the post May 5, succeeding Gilles Gagnon, who will remain with the Canadian company as a strategic adviser and director, Cosciens said Monday.
Biehn most recently served as the chief financial officer of NuTek Natural Ingredients, a "clean-label" and plant-based food ingredient company. Prior to her position s CFO, Biehn was vice president of strategy and marketing. She began her career at packaged food company Conagra, where she held a number of roles including as president responsible for leading the company's international business.
Gagnon last September said Cosciens' board had hired an executive recruiting firm to help identify the company's next president and CEO.
Cosciens, which was created with last year's all-stock merger of Aeterna Zentaris and Ceapro, develops and commercializes a portfolio of what it describes as cosmeceutical, nutraceutical and pharmaceutical products.
Write to Robb M. Stewart at robb.stewart@wsj.com
(END) Dow Jones Newswires
April 14, 2025 07:26 ET (11:26 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.